海盐凝聚“核力”打造同位素产业高地

Core Viewpoint - The establishment of a radioactive drug production project by Novartis in Haiyan marks a significant step towards the large-scale production of radioligand drugs, particularly Lu-177, with an expected production start by the end of 2026 [1][2]. Group 1: Project Developments - Novartis has obtained a Class A radiation safety license for its radioactive drug production project, which has completed its main construction and is set to begin production by the end of 2026 [1]. - The first production line for Lu-177 at Novartis is currently being installed and is expected to be operational within the year, with an anticipated annual output value exceeding 2 billion yuan [2]. - The project has a total investment of 1.06 billion USD and covers an area of 18.8 acres, with construction completed six months ahead of schedule [2]. Group 2: Industry Growth and Investment - Haiyan has established a 1900-acre isotope industrial park, attracting 31 projects with a total investment exceeding 10 billion yuan, aiming to create the largest isotope industry demonstration base in China [1]. - Other companies, such as Faber New Heaven and Zhejiang Aisotuo Technology, are also setting up operations in Haiyan, focusing on various aspects of nuclear medicine and isotope production [2][3]. Group 3: Domestic Production and Export - The Qinshan Nuclear Power Plant has successfully developed the technology for the commercial production of carbon-14 isotopes, achieving the first batch export to Europe in September 2025 [4]. - The plant has scaled up production of key medical isotopes, including Co-60, C-14, Lu-177, Y-90, and Sr-89, and aims to achieve domestic production of Mo-99 and I-131 by 2028 [4]. Group 4: Future Prospects - Haiyan is planning to advance the development of high-energy accelerator isotope production projects, which are expected to significantly increase the availability of rare isotopes like Ac-225 [7]. - The anticipated annual production of 20 curies of Ac-225 could position the isotope industry in Haiyan as a future trillion-yuan industry [7].